Details of elevated troponin levels and clinical outcomes following immune checkpoint inhibitor treatment

Back

Delegates Premium Access

Details of elevated troponin levels and clinical outcomes following immune checkpoint inhibitor treatment

Session: Decoding cardiac biomarkers and coronary interventions in patients with cancer

Topic: Cardio-Oncology

Speaker: Doctor Y. Shibutani (Kashiwa, JP)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Yuma Shibutani

National Cancer Center Hospital East, Kashiwa (Japan)

0 follower

5 more presentations in this session

Revascularization and mortality in ischemic heart disease among children, adolescents and young adults with cancer: Insights from the Rebuc Study

Speaker: Doctor J. Sodling (Norrkoping, SE)

Access

Abstract

Slides

Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.

Speaker: Doctor L. Spadafora (Latina, IT)

Access

Abstract

Slides

Cardiac troponins and anthracycline cardiotoxicity: a sub study of the PROACT trial; are all assays made equal?

Speaker: Doctor G. Gilbert (Middlesbrough, GB)

Access

Abstract

Slides

Long-term outcomes of TAVI in patients with cancer: insights into early and late mortality trends

Speaker: Doctor I. Nardi Agmon (Petah Tikva, IL)

Access

Abstract

Slides

Tracking cardiac troponin dynamics in patients treated with immune checkpoint inhibitors

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)

Access

Abstract

Slides

Access the full session

Decoding cardiac biomarkers and coronary interventions in patients with cancer

Speakers: Doctor Y. Shibutani, Doctor J. Sodling, Doctor L. Spadafora, Doctor G. Gilbert, Doctor I. Nardi Agmon...

Access

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources